Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages

European Journal of Immunology

Volumn 42, Issue 3, 2012, Pages 716-725

  Luheshi, Nadia M ^a   Giles, James A ^a   Lopez Castejon, Gloria ^a   Brough, David ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Caspase 1; Inflammasome; Inflammation; Interleukin 1; Sphingosine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALYCULIN A; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; OKADAIC ACID; PROTEIN SERINE THREONINE KINASE; SPHINGOSINE; URIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; ENZYME INHIBITORS; FLOW CYTOMETRY; INFLAMMASOMES; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OKADAIC ACID; OXAZOLES; PERITONITIS; PHOSPHOPROTEIN PHOSPHATASES; RANDOM ALLOCATION; SPHINGOSINE;

EID: 84859515412     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142079     Document Type: Article

References (45)

1. Rock, K. L., Latz, E., Ontiveros, F. and Kono, H., The sterile inflammatory response. Annu. Rev. Immunol. 2010. 28: 321-342.
2. Allan, S. M., Tyrrell, P. J. and Rothwell, N. J., Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005. 5: 629-640.
3. Dinarello, C. A., Anti-inflammatory agents: present and future. Cell 2010. 140: 935-950.
4. Takeuchi, O. and Akira, S., Pattern recognition receptors and inflammation. Cell 2010. 140: 805-820.
5. Chen, G. Y. and Nunez, G., Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010. 10: 826-837.
6. Schroder, K. and Tschopp, J., The inflammasomes. Cell 2010. 140: 821-832.
7. Cassel, S. L. and Sutterwala, F. S., Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur. J. Immunol. 2010. 40: 607-611.
8. Brough, D. and Rothwell, N. J., Caspase-1-dependent processing of pro-interleukin-1 beta is cytosolic and precedes cell death. J. Cell Sci. 2007. 120: 772-781.
9. Martinon, F., Signaling by ROS drives inflammasome activation. Eur. J. Immunol. 2010. 40: 616-619.
10. Hornung, V. and Latz, E., Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 2010. 40: 620-623.
11. Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S. et al., NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010. 464: 1357-1361.
12. Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A. et al., The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008. 9: 857-865.
13. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A. and Latz, E., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008. 9: 847-856.
14. Wymann, M. P. and Schneiter, R., Lipid signalling in disease. Nat. Rev. Mol. Cell Biol. 2008. 9: 162-176.
15. Dasgupta, S., Adams, J. A. and Hogan, E. L., Maternal alcohol consumption increases sphingosine levels in the brains of progeny mice. Neurochem. Res. 2007. 32: 2217-2224.
16. He, X., Huang, Y., Li, B., Gong, C. X. and Schuchman, E. H., Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol. Aging 2010. 31: 398-408.
17. Rodriguez-Lafrasse, C. and Vanier, M. T., Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem. Res. 1999. 24: 199-205.
18. Kagedal, K., Zhao, M., Svensson, I. and Brunk, U. T., Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 2001. 359: 335-343.
19. Suzuki, E., Handa, K., Toledo, M. S. and Hakomori, S., Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert. Proc. Natl. Acad. Sci. USA 2004. 101: 14788-14793.
20. Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S. and Burtin, P., Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 2010. 9: 883-897.
21. Azuma, H., Takahara, S., Ichimaru, N., Wang, J. D., Itoh, Y., Otsuki, Y., Morimoto, J. et al., Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 2002. 62: 1410-1419.
22. Neviani, P., Santhanam, R., Oaks, J. J., Eiring, A. M., Notari, M., Blaser, B. W., Liu, S. et al., FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J. Clin. Invest. 2007. 117: 2408-2421.
23. Hannun, Y. A. and Obeid, L. M., Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008. 9: 139-150.
24. Yatomi, Y., Ruan, F., Megidish, T., Toyokuni, T., Hakomori, S. and Igarashi, Y., N, N-Dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 1996. 35: 626-633.
25. Juliana, C., Fernandes-Alnemri, T., Wu, J., Datta, P., Solorzano, L., Yu, J. W., Meng, R. et al., Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J. Biol. Chem. 2010. 285: 9792-9802.
26. Lamkanfi, M., Mueller, J. L., Vitari, A. C., Misaghi, S., Fedorova, A., Deshayes, K., Lee, W. P. et al., Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 2009. 187: 61-70.
27. Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P. et al., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006. 440: 228-232.
28. Michel, A. D. and Fonfria, E., Agonist potency at P2X7 receptors is modulated by structurally diverse lipids. Br. J. Pharmacol. 2007. 152: 523-537.
29. Takenouchi, T., Iwamaru, Y., Sugama, S., Sato, M., Hashimoto, M. and Kitani, H., Lysophospholipids and ATP mutually suppress maturation and release of IL-1 beta in mouse microglial cells using a Rho-dependent pathway. J. Immunol. 2008. 180: 7827-7839.
30. Petrilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F. and Tschopp, J., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007. 14: 1583-1589.
31. Chiba, K., Yanagawa, Y., Masubuchi, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M. and Hoshino, Y., FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 1998. 160: 5037-5044.
32. Kono, H., Karmarkar, D., Iwakura, Y. and Rock, K. L., Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death. J. Immunol. 2010. 184: 4470-4478.
33. Habrukowich, C., Han, D. K., Le, A., Rezaul, K., Pan, W., Ghosh, M., Li, Z. et al., Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells. J. Biol. Chem. 2010. 285: 26825-26831.
34. Matsuoka, Y., Nagahara, Y., Ikekita, M. and Shinomiya, T., A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br. J. Pharmacol. 2003. 138: 1303-1312.
35. Gallegos, L. L. and Newton, A. C., Spatiotemporal dynamics of lipid signaling: protein kinase C as a paradigm. IUBMB Life 2008. 60: 782-789.
36. Muruve, D. A., Petrilli, V., Zaiss, A. K., White, L. R., Clark, S. A., Ross, P. J., Parks, R. J. and Tschopp, J., The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008. 452: 103-107.
37. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E. and Fitzgerald, K. A., AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009. 458: 514-518.
38. Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. and Alnemri, E. S., AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009. 458: 509-513.
39. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M. et al., Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004. 430: 213-218.
40. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. and Tschopp, J., Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006. 440: 237-241.
41. Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L. et al., Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009. 28: 1043-1054.
42. Shi, Y., Serine/threonine phosphatases: mechanism through structure. Cell 2009. 139: 468-484.
43. Eichhorn, P. J., Creyghton, M. P. and Bernards, R., Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 2009. 1795: 1-15.
44. Janssens, V., Longin, S. and Goris, J., PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem. Sci. 2008. 33: 113-121.
45. Le Feuvre, R. A., Brough, D., Iwakura, Y., Takeda, K. and Rothwell, N. J., Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J. Biol. Chem. 2002. 277: 3210-3218.